Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Elite Cars in France Can Now Be Purchased With Crypto

Elite Cars in France Can Now Be Purchased With Crypto

CoinspaidmediaCoinspaidmedia2025/12/19 09:34
By:Coinspaidmedia

Porsche and Lamborghini dealerships in France enabled crypto payments by integrating the Tezos-based payment infrastructure from FinTech company Lyzi.

Porsche Centre Montpellier and Lamborghini Bordeaux announced support for crypto transactions. Buyers can now purchase high-end vehicles using BTC, Tezos (XTZ), the stablecoins EURC and USDC, as well as more than 80 other cryptocurrencies.

This became possible through Lyzi’s payment service, which processes transactions with instant conversion to euros. The system removes price volatility risk for dealerships while allowing customers to pay directly from their crypto wallets.

Jean-Pierre Launay, Director of Porsche Centre Montpellier, said the new payment option targets clients who expect both advanced technology and premium service. He noted that the integration blends innovation with a streamlined buying experience. Thomas Hecquet, Director of Lamborghini Centre Bordeaux, added that crypto payments are a natural extension of the brand’s focus on exclusivity and digital convenience.

In 2023, Porsche released a successful NFT collection that reached over $5 million in trading volume at its peak.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs Initiates Tempus AI (TEM.US) with "Neutral" Rating: Diagnostic Business Awaiting Reimbursement Dividends, Data Contracts Enter "Verification Period"

Goldman Sachs has assigned a "Neutral" rating and a $75 price target to Tempus AI; xT and xF reimbursement bonuses are expected, but the sustainability of contracts and competitive advantages with major pharmaceutical companies still needs to be validated.

智通财经2026/09/22 06:56